PEDIATRICS Vol. 115 No. 3 March 2005, pp. 655-661 (doi:10.1542/peds.2004-1238)
Impact of Postnatal Systemic Corticosteroids on Mortality and Cerebral Palsy in Preterm Infants: Effect Modification by Risk for Chronic Lung Disease
* Division of Paediatrics, Royal Women’s Hospital, Melbourne, Australia
Departments of Obstetrics and Gynaecology and of Paediatrics, University of Melbourne, Melbourne, Australia
Department of Child Health, Queen’s University, Belfast, Northern Ireland
|| Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut
¶ Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada
# Department of Pediatrics, Center for Clinical Research and Evidence-Based Medicine, University of Texas Medical School, Houston, Texas
Objective. In preterm infants, chronic lung disease (CLD) is associated with an increased risk for cerebral palsy (CP). However, systemic postnatal corticosteroid therapy to prevent or treat CLD, although effective in improving lung function, may cause CP. The objective of this study was to determine the effect of systemic postnatal corticosteroid treatment on death and CP and to assess any modification of effect arising from risk for CLD.
Methods. Randomized, controlled trials of postnatal corticosteroid therapy for prevention or treatment of CLD in preterm infants that reported rates of both mortality and CP were reviewed and their data were synthesized. Twenty studies with data on 1721 randomized infants met eligibility criteria. The relationship between the corticosteroid effect on the combined outcome, death or CP, and the risk for CLD in control groups was analyzed by weighted meta-regression.
Results. Among all infants who were randomized, a significantly higher rate of CP after corticosteroid treatment (typical risk difference [RD]: 0.05; 95% confidence interval [CI]: 0.02, 0.08) was partly offset by a nonsignificant reduction in mortality (typical RD: –0.02; 95% CI: –0.06 to 0.02). Consequently, there was no significant effect of corticosteroid treatment on the combined rate of mortality or CP (typical RD: 0.03; 95% CI: –0.01 to 0.08). However, on meta-regression, there was a significant negative relationship between the treatment effect on death or CP and the risk for CLD in control groups. With risks for CLD below 35%, corticosteroid treatment significantly increased the chance of death or CP, whereas with risks for CLD exceeding 65%, it reduced this chance.
Conclusions. The effect of postnatal corticosteroids on the combined outcome of death or CP varies with the level of risk for CLD.
Key Words: infant • preterm • survival • cerebral palsy • corticosteroids
Abbreviations: CLD, chronic lung disease • CP, cerebral palsy • RCT, randomized, controlled trial • RR, relative risk • RD, risk difference • CI, confidence interval • IQR, interquartile range
Accepted Aug 5, 2004.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  W. Lenney, A. L. Boner, L. Bont, A. Bush, K-H. Carlsen, E. Eber, B. Fauroux, M. Gotz, A. Greenough, J. Grigg, et al. Medicines used in respiratory diseases only seen in children Eur. Respir. J., September 1, 2009; 34(3): 531 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Yoder, M. Harrison, and R. H. Clark Time-Related Changes in Steroid Use and Bronchopulmonary Dysplasia in Preterm Infants Pediatrics, August 1, 2009; 124(2): 673 - 679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bhandari and V. Bhandari Pitfalls, Problems, and Progress in Bronchopulmonary Dysplasia Pediatrics, June 1, 2009; 123(6): 1562 - 1573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Wilson-Costello, M. C. Walsh, J. C. Langer, R. Guillet, A. R. Laptook, B. J. Stoll, S. Shankaran, N. N. Finer, K. P. Van Meurs, W. A. Engle, et al. Impact of Postnatal Corticosteroid Use on Neurodevelopment at 18 to 22 Months' Adjusted Age: Effects of Dose, Timing, and Risk of Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants Pediatrics, March 1, 2009; 123(3): e430 - e437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Onland, M. Offringa, A. P. De Jaegere, and A. H. van Kaam Finding the Optimal Postnatal Dexamethasone Regimen for Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Systematic Review of Placebo-Controlled Trials Pediatrics, January 1, 2009; 123(1): 367 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Niwas, M Kamat, P Kling, T F Yeh, and S Pyati Postnatal corticosteroids to treat or to prevent chronic lung disease: a survey of neonatologists' practices Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2009; 94(1): F77 - F77. [Full Text] [PDF]
|
|
|
|
|
|
P. M. Lavoie, C. Pham, and K. L. Jang Heritability of Bronchopulmonary Dysplasia, Defined According to the Consensus Statement of the National Institutes of Health Pediatrics, September 1, 2008; 122(3): 479 - 485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Onland, A. P. De Jaegere, M. Offringa, and A. H. van Kaam Effects of Higher Versus Lower Dexamethasone Doses on Pulmonary and Neurodevelopmental Sequelae in Preterm Infants at Risk for Chronic Lung Disease: A Meta-analysis Pediatrics, July 1, 2008; 122(1): 92 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Bal, W. B. de Vries, M. F. M. van Oosterhout, J. Baan, E. E. van der Wall, F. van Bel, and P. Steendijk Long-term cardiovascular effects of neonatal dexamethasone treatment: hemodynamic follow-up by left ventricular pressure-volume loops in rats J Appl Physiol, February 1, 2008; 104(2): 446 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bhandari, C. M. Schramm, C. Kimble, M. Pappagallo, and N. Hussain Effect of a Short Course of Prednisolone in Infants With Oxygen-Dependent Bronchopulmonary Dysplasia Pediatrics, February 1, 2008; 121(2): e344 - e349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kobaly, M. Schluchter, N. Minich, H. Friedman, H. G. Taylor, D. Wilson-Costello, and M. Hack Outcomes of Extremely Low Birth Weight (<1 kg) and Extremely Low Gestational Age (<28 Weeks) Infants With Bronchopulmonary Dysplasia: Effects of Practice Changes in 2000 to 2003 Pediatrics, January 1, 2008; 121(1): 73 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. O'Shea, L. K. Washburn, P. A. Nixon, and D. J. Goldstein Follow-up of a Randomized, Placebo-Controlled Trial of Dexamethasone to Decrease the Duration of Ventilator Dependency in Very Low Birth Weight Infants: Neurodevelopmental Outcomes at 4 to 11 Years of Age Pediatrics, September 1, 2007; 120(3): 594 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. W. Doyle, P. G. Davis, C. J. Morley, A. McPhee, and J. B. Carlin The DART Study of Low-Dose Dexamethasone Therapy: In Reply Pediatrics, September 1, 2007; 120(3): 690 - 691. [Full Text] [PDF]
|
|
|
|
|
|
E. C Eichenwald and A. R Stark Are postnatal steroids ever justified to treat severe bronchopulmonary dysplasia? Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2007; 92(5): F334 - F337. [Full Text] [PDF]
|
|
|
|
|
|
L. W. Doyle, P. G. Davis, C. J. Morley, A. McPhee, J. B. Carlin, and and the DART Study Investigators Outcome at 2 Years of Age of Infants From the DART Study: A Multicenter, International, Randomized, Controlled Trial of Low-Dose Dexamethasonef Pediatrics, April 1, 2007; 119(4): 716 - 721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Levene Minimising neonatal brain injury: how research in the past five years has changed my clinical practice Arch. Dis. Child., March 1, 2007; 92(3): 261 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Parikh, R. E. Lasky, K. A. Kennedy, F. R. Moya, L. Hochhauser, S. Romo, and J. E. Tyson Postnatal Dexamethasone Therapy and Cerebral Tissue Volumes in Extremely Low Birth Weight Infants Pediatrics, February 1, 2007; 119(2): 265 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Stenson Fantoms Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2007; 92(1): F1 - F1. [Full Text] [PDF]
|
|
|
|
|
|
E S Shinwell, L Lerner-Geva, A Lusky, B Reichman, and in collaboration with the Israel Neonatal Network Less postnatal steroids, more bronchopulmonary dysplasia: a population-based study in very low birthweight infants Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2007; 92(1): F30 - F33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Walsh, Q. Yao, J. D. Horbar, J. H. Carpenter, S. K. Lee, and A. Ohlsson Changes in the Use of Postnatal Steroids for Bronchopulmonary Dysplasia in 3 Large Neonatal Networks Pediatrics, November 1, 2006; 118(5): e1328 - e1335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Jobe The New BPD NeoReviews, October 1, 2006; 7(10): e531 - e545. [Full Text] [PDF]
|
|
|
|
|
|
L. K. Washburn, P. A. Nixon, and T. M. O'Shea Follow-up of a Randomized, Placebo-Controlled Trial of Postnatal Dexamethasone: Blood Pressure and Anthropometric Measurements at School Age Pediatrics, October 1, 2006; 118(4): 1592 - 1599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K Sinha and S. M Donn DIFFICULT EXTUBATION IN BABIES RECEIVING ASSISTED MECHANICAL VENTILATION Arch. Dis. Child. Ed. Pract., August 1, 2006; 91(2): ep42 - ep46. [Full Text] [PDF]
|
|
|
|
|
|
T. T. Wilson, L. Waters, C. C. Patterson, C. G. McCusker, N. M. Rooney, N. Marlow, and H. L. Halliday Neurodevelopmental and Respiratory Follow-up Results at 7 Years for Children From the United Kingdom and Ireland Enrolled in a Randomized Trial of Early and Late Postnatal Corticosteroid Treatment, Systemic and Inhaled (the Open Study of Early Corticosteroid Treatment). Pediatrics, June 1, 2006; 117(6): 2196 - 2205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. W. Doyle, P. G. Davis, C. J. Morley, A. McPhee, and J. B. Carlin Reopening the Debate on Corticosteroids: In Reply Pediatrics, June 1, 2006; 117(6): 2322 - 2323. [Full Text] [PDF]
|
|
|
|
|
|
N. N. Finer, R. J. Powers, C.-h. S. Ou, D. Durand, D. Wirtschafter, J. B. Gould, and for the California Perinatal Quality Care Collabor Prospective Evaluation of Postnatal Steroid Administration: A 1-Year Experience From the California Perinatal Quality Care Collaborative Pediatrics, March 1, 2006; 117(3): 704 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. W. Doyle, P. G. Davis, C. J. Morley, A. McPhee, J. B. Carlin, and and the DART Study Investigators Low-Dose Dexamethasone Facilitates Extubation Among Chronically Ventilator-Dependent Infants: A Multicenter, International, Randomized, Controlled Trial Pediatrics, January 1, 2006; 117(1): 75 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Tyson and S. Saigal Outcomes for Extremely Low-Birth-Weight Infants: Disappointing News JAMA, July 20, 2005; 294(3): 371 - 373. [Full Text] [PDF]
|
|
|
|
|
|
H. Aly Mechanical Ventilation and Cerebral Palsy Pediatrics, June 1, 2005; 115(6): 1765 - 1767. [Full Text] [PDF]
|
|
|
|
|
|
C. L. Bose and M. M. Laughon Corticosteroids and Chronic Lung Disease: Time for Another Randomized, Controlled Trial? Pediatrics, March 1, 2005; 115(3): 794 - 794. [Full Text] [PDF]
|
|
